SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-268255
Filing Date
2023-11-01
Accepted
2023-11-01 16:37:35
Documents
5
Effectiveness Date
2023-11-01

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d544392ds8.htm S-8 56987
2 EX-5.1 d544392dex51.htm EX-5.1 7652
3 EX-23.1 d544392dex231.htm EX-23.1 2182
4 EX-FILING FEES d544392dexfilingfees.htm EX-FILING FEES 16054
5 GRAPHIC g544392g1031214532517.jpg GRAPHIC 2771
  Complete submission text file 0001193125-23-268255.txt   88000
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275250 | Film No.: 231368799
SIC: 2834 Pharmaceutical Preparations